Leap Therapeutics, Inc. (LPTX) Misses Q2 EPS by 5c

Leap Therapeutics, Inc. (NASDAQ: LPTX) reported Q2 EPS of ($0.15), $0.05 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Leap Therapeutics, Inc. (LPTX) click here.

You May Also Be Interested In

• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• SailPoint Technologies Holdings (SAIL) PT Raised to $25 by Cantor Fitzgerald on Solid Checks
• Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case